
This systematic review and meta‐analysis compare weight loss between GLP‐1 receptor agonists and bariatric surgery. The databases MEDLINE, MEDLINE In‐Process, MEDLINE Epubs Ahead of Print, Embase Classic + Embase (OvidSP), and Cochrane (Wiley) were searched from inception to April 21, 2021, for randomized controlled trials and observational studies. Six studies, encompassing 332 patients, were included. In adults with obesity, bariatric surgery still confers the highest reductions in weight and BMI but confers similar effects in glycemic control when compared with GLP‐1 receptor agonists.
Like
Save
Share